LifePoint Health, Inc. (LPNT) Cut to Sell at Zacks Investment Research
Zacks Investment Research cut shares of LifePoint Health, Inc. (NASDAQ:LPNT) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning.
According to Zacks, “LifePoint Health’s stock has underperformed the industry in the last six months. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 30 days.”
LPNT has been the topic of a number of other research reports. TheStreet cut shares of LifePoint Health from a b- rating to a c+ rating in a report on Wednesday, August 16th. BidaskClub upgraded shares of LifePoint Health from a hold rating to a buy rating in a research report on Friday, June 30th. Morgan Stanley initiated coverage on shares of LifePoint Health in a research report on Tuesday, June 6th. They issued an equal weight rating and a $65.00 target price for the company. Barclays PLC increased their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the company an equal weight rating in a research report on Monday, May 1st. Finally, Leerink Swann upgraded shares of LifePoint Health from a market perform rating to an outperform rating and increased their target price for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of $66.18.
Shares of LifePoint Health (LPNT) opened at 57.75 on Tuesday. LifePoint Health has a one year low of $50.60 and a one year high of $70.95. The stock has a 50 day moving average of $59.84 and a 200 day moving average of $62.50. The stock has a market cap of $2.32 billion, a P/E ratio of 12.93 and a beta of 0.86.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company earned $0.69 EPS. The company’s revenue for the quarter was up .2% compared to the same quarter last year. Equities analysts expect that LifePoint Health will post $4.06 EPS for the current fiscal year.
In other news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now owns 504,535 shares in the company, valued at approximately $32,365,920.25. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the transaction, the chairman now owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.
Several institutional investors have recently bought and sold shares of LPNT. Zurcher Kantonalbank Zurich Cantonalbank raised its position in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares during the period. LS Investment Advisors LLC raised its position in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares during the period. US Bancorp DE raised its position in LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares during the period. Bank of Montreal Can raised its position in LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares during the period. Finally, Shelton Capital Management acquired a new position in LifePoint Health during the second quarter valued at $205,000. Institutional investors own 99.53% of the company’s stock.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.